Correlation Between Mineralys Therapeutics, and Surrozen

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Surrozen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Surrozen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Surrozen, you can compare the effects of market volatilities on Mineralys Therapeutics, and Surrozen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Surrozen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Surrozen.

Diversification Opportunities for Mineralys Therapeutics, and Surrozen

0.12

Correlation Coefficient

Mineralys Therapeutics,  Surrozen

Average diversification

The 3 months correlation between Mineralys and Surrozen is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Surrozen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Surrozen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Surrozen go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Surrozen

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.52 times more return on investment than Surrozen. However, Mineralys Therapeutics, is 1.52 times more volatile than Surrozen. It trades about 0.08 of its potential returns per unit of risk. Surrozen is currently generating about -0.04 per unit of risk. If you would invest  987.00  in Mineralys Therapeutics, Common on January 9, 2025 and sell it today you would earn a total of  218.00  from holding Mineralys Therapeutics, Common or generate 22.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Surrozen

Mineralys Therapeutics,

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.

Surrozen

Risk-Adjusted Performance

Very Weak

Over the last 90 days Surrozen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Mineralys Therapeutics, and Surrozen

The main advantage of trading using opposite Mineralys Therapeutics, and Surrozen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Surrozen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen will offset losses from the drop in Surrozen's long position.

The idea behind Mineralys Therapeutics, Common and Surrozen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.